MUC1 is a novel regulator of ErbB1 receptor trafficking

M R Pochampalli1, R M el Bejjani, J A Schroeder

  • 1Department of Molecular and Cellular Biology, Arizona Cancer Center and Bio5 Institute, University of Arizona, Tucson, AZ 85724, USA.

Oncogene
|September 20, 2006
PubMed

Insights

The oncogenic MUC1 glycoprotein inhibits the degradation of activated erbB1 receptors, increasing cellular erbB1 levels. This MUC1-mediated protection may promote cancer development by stabilizing erbB1 signaling.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • ErbB receptors are crucial for cell growth and survival.
  • The oncogenic MUC1 glycoprotein interacts with and is acted upon by erbB1.
  • Activated erbB1 is normally degraded or recycled via endocytosis.

Purpose of the Study:

  • To investigate the effect of MUC1 on the degradation of activated erbB1.
  • To determine if MUC1 influences erbB1 stability and signaling pathways.

Main Methods:

  • RNA interference (RNAi) for MUC1 knockdown.
  • Overexpression constructs for MUC1.
  • Ligand stimulation of erbB1.
  • Biotinylation of surface proteins.
  • Analysis of erbB1 ubiquitination and recycling.

Main Results:

  • MUC1 expression inhibits the degradation of ligand-activated erbB1 in breast epithelial cells.
  • MUC1 increases total cellular erbB1 levels by protecting it from degradation.
  • MUC1 protects cell-surface erbB1 from degradation, increasing internalization and recycling.
  • MUC1 reduces EGF-stimulated ubiquitination of erbB1.

Conclusions:

  • MUC1 is a potent regulator of erbB1 receptor stability after activation.
  • MUC1-mediated inhibition of erbB1 degradation may contribute to cellular transformation and cancer progression.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...